<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: Pupillometry is a non-invasive measurement technique based on the pupillary response to specific sensoric, mental and emotional variables </plain></SENT>
<SENT sid="1" pm="."><plain>After topical application of a <z:chebi fb="0" ids="48873">cholinergic antagonist</z:chebi> (tropicamide) an increased pupillary <z:mpath ids='MPATH_66'>dilatation</z:mpath> response in Alzheimers s disease patients was described ("receptor test") </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of the present study was to evaluate the usefulness of the 0.01% tropicamide receptor test in differentiating types of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHOD: 425 patients (159 men, 266 women, mean age 75 years) of the Memory Clinic of the SMZ Ost Vienna, Austria were included in the study </plain></SENT>
<SENT sid="4" pm="."><plain>195 patients suffered from a <z:hpo ids='HP_0000726'>dementia</z:hpo> in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> with <z:hpo ids='HP_0003584'>late onset</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>-10: F00.1), 42 from <z:hpo ids='HP_0000726'>dementia</z:hpo> in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> with early <z:hpo ids='HP_0003674'>onset</z:hpo> (F00.0), 71 from vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (F01), 34 from Lewy-Body <z:hpo ids='HP_0000726'>dementia</z:hpo> (F03) and 83 from mixed <z:hpo ids='HP_0000726'>dementia</z:hpo> (F00.2) </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were investigated by means of a computer-assisted pupillometer </plain></SENT>
<SENT sid="6" pm="."><plain>The pupillary diameter of the left eye was measured 4 times (baseline=0 minutes, after 20, 40 and 60 minutes) </plain></SENT>
<SENT sid="7" pm="."><plain>4 minutes after baseline one drop of 0.01% tropicamide solution was installed onto the left eye of the patients </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: At baseline the pupillary diameter was largest in Lewy-Body <z:hpo ids='HP_0000726'>dementia</z:hpo>, smallest in vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Significant differences were observed between vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> and early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:hpo ids='HP_0000726'>dementia</z:hpo> in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> as well as between Lewy-Body <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:hpo ids='HP_0000001'>all</z:hpo> other <z:hpo ids='HP_0000726'>dementia</z:hpo> syndromes (except <z:hpo ids='HP_0000726'>dementia</z:hpo> in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> with early <z:hpo ids='HP_0003674'>onset</z:hpo>) </plain></SENT>
<SENT sid="10" pm="."><plain>The 0.01% tropicamide receptor test made it possible to differentiate early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:hpo ids='HP_0000726'>dementia</z:hpo> in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> from vascular and mixed <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: Utilizing pupillometry in combination with the 0.01% tropicamide receptor test allows to discriminate between different <z:hpo ids='HP_0000726'>dementia</z:hpo> types of, as demonstrated in our study </plain></SENT>
</text></document>